Major Cause of Inflammatory Bowel Disease Discovered June 5, 2024 — Researchers have discovered a new biological pathway ... Crohn's Patients With Advanced Therapy Leads to Dramatic Improvements ...

VRG50635 was discovered using Verge's AI-powered discovery platform ConVERGE which maps ... biological underpinnings of diseases using data on DNA, RNA, and protein profiles to identify new ...

Researchers there don’t rely on any particular therapy. Instead they analyze ... type 2 diabetes, inflammatory bowel disease, and atrial fibrillation. The scorecard builds on an unsettling ...

Intestinal virome in IBD ... terms of target bacteria eradication, though clinical effects on disease activity beyond the resolution of the infection are difficult to infer. In addition to the animal ...

Identifying disease-related genes is a critical and challenging task for unveiling the biological mechanisms behind these diseases ... the treatment effect of breast cancer patients, targeted therapy ...

More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...

More than 1,000 genes may serve as possible treatment targets for individuals with kidney ... By creating the most complete and detailed genetic "map" of kidney function to date, the researchers ...

An antibiotic used to treat infective diarrhoea could be an effective drug for a type of inflammatory bowel disease, a new study has found.

The Vancouver-based company uses generative AI to create biologic drugs, with 20 “active programs” underway, many of them ...

The Democratic Legislative Campaign Committee (DLCC) rolled out its target map for the 2025 and 2026 campaign cycles on Tuesday. As a part of what the DLCC called its “battleground chambers ...

Table 1. Summary of biological therapies of inflammatory bowel disease. Target or supplement Agent name (nature) Application Usage Ref. Anti-TNF Infliximab (mAb) UC, CD, approved by US FDA iv.

Results from a new study published in Clinical and Translational Immunology found that dual-target antibody therapy can enhance cancer-fighting T cells more effectively than current single-target ...